Pcos
Pcos
PCOS-Epidemiology
• PCOS affects 6.5 to 8% (NIH 1990) of the female population of
reproductive age.
• It’s prevalence among infertile women is 15% to 20%.
• PCOS accounts for 95% of cases of hyperandrogenism
• PCOS is responsible for over 20% of all cases of amenorrhea
• PCOS is responsible for up to 75% of all cases of anovulatory
infertility.
Pathophysiology
Polycystic Ovarian Syndrome PCOS is believed to be
a genetically inherited metabolic and gynecological disorder.
A repetitive vicious cycle occurs with hormones resulting in
the progression of PCOS. To begin with, failure of an ovary to
release oocyte results in increased levels of androgen
production released from the ovaries as well as the adrenal
cortex. The excess androgen hormones in the system have a
twofold effect. First, androgens are stored in adipose tissue
where they are then converted into estrogen. Excess
androgens then result in an increased production of Sex
Hormone Binding Globulin (SHGB). This increased SHGB then
has the consequence of an even greater fabrication of
androgens and estrogens. Thus the cycle begins. The cause of
the excess androgen production has been correlated to
surplus Luteinizing hormone (LH) stimulation resulting in the
presence of cystic changes in the ovaries.
• Gonadotropin secretion
• Insulin secretion
• Androgen biosynthesis
Diagnosis
There is no single specific test that can be used to accurately
diagnose Polycystic Ovarian Syndrome. Rather a
comprehensive examination needs to be carried out by a
clinician which involves a detailed history, physical
examination and investigative procedures. Clinicians should
focus on taking a detailed menstrual history for any
irregularities, any significant change in the patient's weight
and physical appearance (acne, alopecia, terminal hair,
acanthuses nigricans, skin tags)Investigations that could help
arrive at a definite diagnosis include:
Treatment